期刊文献+

可溶性髓系细胞触发受体1在脓毒症诊疗中的研究新进展 被引量:6

The new progress of sTREM-1 in the diagnosis and treatment of sepsis
原文传递
导出
摘要 人可溶性髓系细胞触发受体1(sTREM-1)是新近发现的与炎症反应密切相关的免疫球蛋白家族成员,是炎症反应的敏感标记物,多种病原微生物感染均能使sTREM-1高度表达,其通过TOLL样受体作用,参与促炎因子的分泌,在脓毒症发生发展过程中扮演着重要角色,是近年来脓毒症诊断及病情监测中较为敏感可靠的新指标。因此有必要研究sTREM-1在脓毒症病程发生发展中的特点及作用,对预防脓毒症的发生及合理治疗、病情预后评估等方面具有重要意义。 The Strem-1 is a member of the immunoglobulin family, which is recently found to be closely associated with the inflammatory and a sensitive marker of the inflammatory response. Many pathogenic microorganisms infection can make sTREM-1 highly expressed, it is involved in the secretion of pro-inflammatory factors by the role of TOLL receptors, and played an important role in the development of sepsis. It is a moresensitive and reliable indicator in the diagnosis and monitoring of sepsis in recent years. It is necessary to study the characteristics and role of sTREM-1 in the development of sepsis, and it has important significance in preventing the occurrence of sepsis and reasonable treatment or prognosis evaluation.
出处 《中国综合临床》 2016年第3期279-281,共3页 Clinical Medicine of China
  • 相关文献

参考文献17

二级参考文献157

共引文献139

同被引文献64

引证文献6

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部